$EIDX: Eidos Therapeutics Announces Positive Phase 2 Data for AG10 in …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 (GLOBE NEWSWIRE) — Eidos Therapeutics, Inc. (Eidos) (NASDAQ:EIDX), today announced positive results of its Phase 2 clinical trial studying AG10 …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12675610/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptom

Related News:

$EIDX: Eidos launches late-stage study of AG10 in ATTR-CM

$PG $EIDX: 12 Stocks That Pass The ‘Bollinger’ Test

$HTGC $EIDX: Hercules Capital Completes Outstanding Fourth Quarter …

$EIDX $RWGE: Is Eidos Therapeutics, Inc. (EIDX) A Good Stock To Buy?

$NTP $EIDX: Is Nam Tai Property Inc (NTP) A Good Stock To Buy?

$EIDX $MNK: Key events next week – healthcare

$EIDX: Eidos Therapeutics Receives Positive Opinion for Orphan …

$EIDX: Eidos Therapeutics to Present Phase 2 Data for AG10 in TTR …

$EIDX: FDA Grants Orphan Drug Designation to Eidos Therapeutics …

$PFE $ALNY $IONS $AKCA $EIDX $SPX: Pfizer stock drops 2% as positive rare-disease drug results won’t stop competitors

Latest News:

$DWDP: Is DowDuPont a Buy?

$T $VIA: Viacom and AT&T Negotiate to Avert Major Programming Blackout

$MGM $CZR $VICI: How Wynn Resorts Could Free Up Billions in Cash

$PYX $RKDA: CBD is booming. But US farmers struggle to keep up with demand for industrial hemp

$GE: 3 Stocks Looking to Benefit From GE’s Misfortunes

$LEVI: Before the Levi’s IPO, there was the 1985 buyout led by iconoclastic S.F. investor Warren Hellman

$TLRY $CGC: 1 Figure That Guarantees a Canadian Marijuana Oversupply Is …

$AAPL $GS: Steve Jobs was trying to revolutionize TV almost a decade ago — now we’ll find out Apple’s plan

$SBUX: Starbucks Increasing its Environmental Commitment

$GH $ROKU: 3 Stocks That Are Up More Than 100% in 2019

$SUN: Is Sunoco a Buy?